QUOTE AND NEWS
FierceBiotech  Aug 23  Comment 
Novartis brings in new CEO to clean up Korean branch; Achillion poaches CMO from uniQure in clinical leader revamp; and Sensei hires new CMO as it eyes phase 2 trial. Those moves plus more hirings, firings and retirings throughout the industry.
FierceBiotech  Aug 21  Comment 
Achillion Pharmaceuticals has named Steven Zelenkofske as executive vice president and chief medical officer. The appointment ends Zelenkofske’s brief time as CMO of uniQure, the company he joined last summer from AstraZeneca.
SeekingAlpha  Aug 15  Comment 
Motley Fool  Jun 22  Comment 
Which stock wins in a battle between these two clinical-stage biotechs?





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki